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Zinc balance in combined zinc deficiency and uremia. In order to
evaluate whether the hypozincemia associated with chronic renal
failure represents true negative zinc balance, male Lewis rats were
randomized and pair-fed zinc replete (+ Zn) or deplete (—Zn) diets.
Subsequently, each animal underwent one- and two-thirds nephrecto-
my, or a sham operation. Complete balances for zinc, calcium, and
magnesium were determined weekly before and after nephrectomy. At
sacrifice, —Zn animals had significantly lower (P < 0.005) plasma zinc
levels compared to controls. Nephrectomized (N) animals had signifi-
cantly elevated plasma creatinine (P < 0.005), diminished creatinine
clearances (P < 0.005), and increased urinary flows (P < 0.005) and
protein excretion (P < 0.01) compared to sham-operated (5) controls.
Zinc nutritional status had no effect on these parameters in animals with
comparable renal function. —Zn/N animals had consistently signifi-
cantly elevated (P < 0.005) urinary zinc excretion compared with
—Zn/S with similar plasma zinc concentrations. Urinary zinc excretion
correlated with urinary flow (r = 0.739, P < 0.005), urinary protein (r =
0.635, P <0.01) and urinary calcium excretion (r = 0.855, P <0.005) in
—Zn groups. —Zn/N rats had a significantly larger fecal zinc excretion
for the first week post-nephrectomy, compared to —Zn/S controls (P <
0.005). This resulted in negative zinc balance in —Zn/N animals,
compared to their pre-nephrectomy balance (P < 0.05) or to —Zn/S
controls for the first (P < 0.005) and second (P < 0.05) weeks. —Zn/N
rats had lower (P < 0.02) hepatic zinc concentrations compared to the
—Zn/S group. We conclude that increased urinary and fecal zinc
excretion contributed to the development of negative zinc balance in
zinc depleted animals with early chronic renal insufficiency. Hepatic
compartmentalization of zinc does not contribute to the hypozincemia
of —Zn uremic rats. Zinc balance in uremic animals is primarily
determined by nutritional zinc.
Zinc deficiency is a clinical entity associated with disorders
of sensory, sexual and immune function in humans and labora-
tory animals [1—5]. Hypozincemia is common in patients with
both chronic renal insufficiency, and in patients treated for
end-stage renal disease with hemodialysis [6—9], and may ac-
count for some of the symptoms associated with uremia [10—
14]. Early reports of zinc metabolism in humans with chronic
renal insufficiency suggest that inappropriately elevated urinary
zinc excretion, when normalized for diminution in glomerular
filtration rate might contribute to total body zinc loss [6, 7].
Although indirect tests of gastrointestinal zinc absorption, such
as the zinc tolerance test, have been used to evaluate the role of
the gastrointestinal tract in zinc homeostasis in patients with
Received for publication April 13, 1987
and in revised form November 16, 1987
© 1988 by the International Society of Nephrology
chronic renal disease [15—17], direct measurements of zinc
absorption have not been performed in patients or animals with
uremia. Other studies have suggested that the hypozincemia
might be related to a redistribution of total body zinc [6, 18].
Therefore, it has not been clear whether hypozincemia in
chronic renal insufficiency represents true total body zinc
depletion or a shift of zinc from extracellular to intracellular
compartments. Most studies have not considered the decreased
food intake, diminution in growth rates, and anorexia in sub-
jects with zinc deficiency [5, 19, 20] in analyzing subsequent
findings. To our knowledge, the response of the gastrointestinal
tract to changes in zinc homeostasis in chronic renal insuffi-
ciency has not previously been investigated in balance studies.
In the present study, we therefore assessed the roles of renal
insufficiency and zinc depletion separately on the renal and
gastrointestinal excretion of zinc.
Methods
Forty-one male Lewis rats (ages 6 to 8 weeks) were individ-
ually housed for the duration of the study in non-galvanized
plastic metabolic cages in which separate, complete 24 hour
collections of stool and urine were made, uncontaminated by
food, as previously described [211. Animals were kept at 23°C
on a twelve hour light-dark cycle. The animals were given ad lib
a zinc deficient AIN-76a purified diet (Dyets, Inc., Bethlehem,
Pennsylvania, USA), composed of 0.5% calcium, 0.1% sodium,
0.4% phosphorus, 0.05% magnesium, and less than 0.00007%
zinc, to which 5 mg of zinc acetate per day per animal had been
added. The composition of the diet is given in Table 1. Animals
were allowed ad lib access to deionized distilled water. After a
two week equilibration period, measures were made of individ-
ual animal's weights, following which the animals were paired
by weight and each paired individual assigned to one of two
groups. One paired group had the zinc supplementation discon-
tinued to ensure a zinc deficient diet (—Zn). Each member of
the second paired group continued to have its diet supple-
mented with 5 mg of zinc acetate per day given separately at the
beginning of feeding to ensure zinc repletion (+Zn). The
animals underwent daily pair feeding in order to maintain
growth rates, and caloric, protein, carbohydrate, fat and min-
eral intake at comparable levels, except for zinc acetate.
Zinc replete paired animals were fed the amount eaten by
their paired deplete partner the previous day. Animals were
weighed once a week during the study. After two weeks of pair
feeding, half of each paired group underwent left nephrectomy
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Ingredients
gIlOO g
diet Vitamin composition
mg/kg
diet
Egg white 20.0 Thiamine 6
Corn starch 15.0 Riboflavin 6
Sucrose 50.3 Piridoxine 7
Cellulose 5.0 Niacin 30
Corn oil 5.0 Calcium Pantothenate 16
Choline bitartrate 2.0 Folate 2
Calcium 0.52 Biotin 0.2
Phosphorus 0,40 Cyanocobalamin 10
Sodium 0.10 Vitamin A 4000 IU
Potassium 0.36 Vitamin E 50 IU
Magnesium 0.05 Vitamin D3 1000 IU
Zinc <0.00007
Trace elements 0.001
(Fe, Cu, Mn, Cr)
(N)and ligation of the upper and lower pole of the right kidney,
under light ether anesthesia and sterile conditions. The other
half of each group underwent a sham operation (S), which
included the exposure of the appropriate kidney, and manipu-
lation of the renal capsule. The development of uremia was
monitored by serial determinations of plasma creatinine con-
centration obtained by tail vein puncture, and creatinine clear-
ance. Pair feeding continued according to renal function with
zinc replete animals fed the amount of food consumed by zinc
deplete pairs. During a three to four week recovery period
throughout which pair feeding on zinc deplete and replete diets
continued, urinary excretion and fecal excretion studies were
repeated at weekly intervals. At the end of this period all
animals were weighed and sacrificed by exsanguination (Fig. I).
Samples of hepatic tissue were obtained from twenty-nine
animals undergoing balance studies at the time of sacrifice.
These samples were frozen for subsequent analysis of tissue
zinc.
All glassware was washed with Acationox (American Scien-
tific Products, McGaw Park, Illinois, USA) a metal-free deter-
gent, and deionized distilled water to minimize ionic contami-
nation. All blood samples were collected by cardiac puncture
under light ether anesthesia using stainless steel needles and
plastic syringes. Samples were collected in 0.06 ml 4% sodium
citrate/mI whole blood and transferred to zinc-free polypropyl-
ene test tubes. Samples were centrifuged, cells separated, and
the plasma frozen for subsequent analysis. Twenty-four hour
urine samples were collected, the volumes measured and fro-
zen. Subsequently, aliquots were diluted appropriately to mea-
sure sodium, calcium, magnesium, zinc, creatinine and protein
concentrations.
Urinary and plasma zinc concentrations were measured by
atomic absorption spectrophotometry (Varian Techtron AA 5,
Palo Alto, California, USA) according to methods previously
described [21]. In brief, urine samples were aspirated directly
into the spectrophotometer while plasma samples were diluted
1:5 with deionized distilled water. The sample absorbance of
light at 213.9 nm was then compared to absorbances for a
standard curve obtained using guaranteed commercially pre-
pared standard solutions (Fisher Scientific, Silver Spring, Mary-
land, USA) [22]. Urine and plasma creatinine concentrations
were measured according to a modification of the method of
Fig. 1. Experimental design. Animals were placed on ad lib, zinc
deficient diets supplemented with zinc, then randomized to pair-fed zinc
deficient and supplemented diets. Half of each group was nephrecto-
mized. Pair feeding continued for four weeks until sacrifice.
Folin and Wu [23]. Urinary protein concentration was mea-
sured by a modification of the Lowry method [24]. Urinary
calcium and magnesium concentrations were determined by
atomic absorption spectrophotometry as previously described
[21]. Lanthanum chloride (0.5%) was included in all standards
and unknown calcium solutions to correct for phosphate inter-
ference. Urinary sodium concentration was determined by
flame photometry (Model IL-143, Instrumentation Laboratory,
Lexington, Massachusetts, USA).
The 24-hour fecal samples were collected in zinc-free poly-
propylene tubes, weighed, frozen, lyophilized, ground into
powder and blended. 0.25 Gram samples were digested at 70°C
in 30% hydrogen peroxide and extracted in cold, dilute nitric
acid. Residues were centrifuged and washed in deionized
distilled water. The washings were combined with the original
extract and brought to standard volumes according to the
method of Chang and Bloom [25]. Samples were analyzed by
atomic absorption spectrophotometry for determination of fecal
zinc, calcium and magnesium as described above [21]. Hepatic
tissue was dried, lyophilized, and digested in 30% hydrogen
peroxide and extracted in cold dilute nitric acid, and then
treated similarly to fecal residue.
Balance was established for zinc, calcium and magnesium
during three day periods preoperatively and at the end of the
first, second and third post-operative weeks by collecting all
feces and urine and recording food consumption. Dietary intake
and urinary and fecal cation excretion rates were calculated as
the average per 100 g per day for each animal for each of the
balance periods. Balance was calculated as the daily difference
between dietary cation intake per 100 g per animal and the sum
of urinary and fecal cation excretion per 100 g per animal.
Creatinine clearance was measured from timed 24-hour urine
collections, using the standard formula, total urinary creatinine
excretion per 24 hours per plasma creatinine concentration [23].
Statistical comparisons of paired group differences were
performed using paired and unpaired Student's 1-test as appro-
priate [261. Differences between weights during growth were
analyzed using analysis of variance [271 evaluating Duncan's
Table 1. Zinc deficient AIN 76A purified diet Male Lewis rats
Metabolic cages
Zinc replete diets
2 week equilibration
/ Pair feeding
Zinc deplete diet
2 weeksI
2 weeksl
4 weeks
Zinc replete diet/\ /\
12/3 nephrectomy Sham 12/3 nephrectomy Sham
Sacifice: determination of zinc, calcium, magnesium balance,
urinary sodium and creatinine determination, plasma creatinine
and zinc
+Zn/N +Zn/S —Zn/N —Zn/S
a
a)
a)
0
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Fig. 2. Gron'tl, responses during pair feeding. (•) P
< 0.05 +Zn/S vs. —Zn/N. Animals in all groups
gained similar amounts of weight. After surgery,
growth rate diminished in all groups. At sacrifice,
the only difference was between +Zn/S and —Zn/N
groups.
multiple range test [26] for weights. Data are expressed as mean
SEM.
Results
The nephrectomy procedure was followed by a period of
weight loss in all groups, probably due to anorexia post-surgery
(Fig. 2). Thereafter, +Zn animals grew rapidly, and by four
weeks post-nephrectomy showed a net gain compared to their
pre-surgery weights. The —Zn animals never recovered the
weight lost immediately following surgery. There were no
significant differences between nephrectomized and sham con-
trols' weights at any time during the study for +Zn or —Zn
pairs. There were no differences between weights of —Zn and
+Zn groups of comparable renal function at any time. By three
and four weeks after surgery, + Zn/S operated controls weighed
more than —Zn/N animals (P < 0.05) despite pair feeding.
There were no significant differences in weight between any
other groups during the experimental observation period. Due
to this weight variation and to normalize balance during growth
periods, cation excretion has been calculated per 100 g body
weight.
All groups had comparable plasma zinc concentrations when
maintained on zinc supplementation prior to the initiation of
zinc depletion. There was no difference in plasma zinc concen-
tration between nephrectomized and sham groups of compara-
ble zinc nutritional status at the time of sacrifice (Table 2).
Therefore plasma zinc concentration data were pooled and
analyzed as +Zn versus —Zn. At the time of sacrifice, —Zn
animals had plasma zinc concentrations about one third that of
controls, which was significantly lower than that of +Zn
animals (P < 0.005).
The extent of renal insufficiency was monitored using plasma
creatinine concentration and creatinine clearance. Plasma con-
centration and clearance of creatinine were similar for all
groups of animals before and after initiation of zinc deficiency,
prior to nephrectomy. Subsequently, individual animals having
less than a 50% reduction in creatinine clearance compared to
sham operated controls were judged to be inadequately nephrec-
tomized and their data were excluded from analysis. There was
Table 2. Plasma zinc concentration and renal function
Pre-Zn
deficiency Pre-NPX Sacrifice
Plasma zinc Eq/liter
+Zn/S (N = 10) 41.9 2.5 44.6 1.0 41.3 2.7
+Zn/N (N = 8) 39.2 3.3 41.8 0.94 39.6 3.4
—Zn/S (N 12) 43.2 2.4 16.4 12b 12.2 0.78"
—Zn/N (N = II) 42.6 3.0 17.4 10b 13.7 l.7'
Plasma creatinine
mg/dl
+Zn/S 0.48 0.03 0.40 0.04 0.51 0.03
+Zn/N 0.49 0.05 0.38 0.03 1.2 0.1l
—Zn/S 0.51 0.04 0.40 0.02 0.52 0.05
—Zn/N 0.49 0.03 0.43 0.03 1.6 0.27'
Creatinine clearances
mi/mm/kg
+Zn/S 4.7 0.47 5.8 0.81 4.4 0.40
+Zn/N 4.9 0.57 6.0 0.53 1.3 0.23a
—Zn/S 4.5 0.54 5.5 0.57 4.4 0.38
—Zn/N 4.5 0.51 5.4 0.67 1.1 0.17
a P < 0.005, compared to shams
b p < 0.005, compared to +Zn
no significant difference between mean plasma creatinine con-
centrations or creatinine clearances (not shown) in any group at
two weeks post-nephrectomy compared to their respective
mean values at sacrifice. At sacrifice, the mean creatinine
clearance of the nephrectomized groups was 27% that of the
sham operated groups (P < 0.005, Table 2). Plasma creatinine
concentrations of nephrectomized animals at sacrifice were
280% that of sham operated controls (P < 0.005). There was no
significant difference in urinary creatinine excretion among any
group at sacrifice.
Urine volumes in rats with different zinc nutritional states at
sacrifice were similar. There was a significant difference (P <
0.005) in urine volumes in rats with renal insufficiency (9.1 2.7
ml/24 hrs) compared with sham controls (4.9 1.8 ml/24 hrs) at
sacrifice. Urinary zinc excretion and urine volume correlated
significantly (r = 0.605, P < 0.05) only in the —Zn/S group at
sacrifice. When both zinc deficient groups were combined for
1 2 3 4 5 6 7 8 9
Time in weeks
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Table 3. 24-Hour urinary excretion (per 100 grams)
analysis, urinary zinc excretion correlated (r = 0.739, P <
0.005) with urinary flow. There was no correlation between
urinary flow and zinc excretion in zinc replete groups, Urinary
zinc excretion at sacrifice correlated with the ratio of urinary
flow and creatinine clearance (r — 0.67, P < 0.005) only in
pooled zinc deficient groups. Urinary zinc excretion did not
correlate with this ratio in any one of the four individual groups.
Nephrectomized animals had at least a 71%, significant (P <
0.005) increase in urinary protein excretion throughout the
experimental period compared to all sham operated controls
(Table 3). The proteinuria within groups increased with time
after nephrectomy regardless of zinc nutritional status. There
was a significant increase (P < 0.05) in urinary protein excretion
in the pooled zinc deficient animals compared to all zinc replete
controls only during the first week post-nephrectomy. By the
third week after nephrectomy each group with renal insuffi-
ciency had significantly (P < 0.005) increased urinary protein
excretion compared with sham operated animals. There was no
difference in urinary protein excretion related to zinc nutrition
for the duration of the experiment after nephrectomy.
Since before nephrectomy there was no difference between
urinary zinc excretion in animals with comparable zinc nutri-
tional status these data were pooled for analysis. After random-
ization to +Zn and —Zn diets, before nephrectomy, zinc
excretion fell significantly in —Zn animals to 18% that of +Zn
controls (P <0.005). After nephrectomy urinary zinc excretion
was consistently significantly increased in —Zn/N animals
compared to —Zn/S controls with similar plasma zinc concen-
trations (P < 0.005, for all observations). The difference in-
creased in succeeding weeks, progressing from 173% to 210% of
—Zn/S controls' urinary zinc excretion at sacrifice. Urinary
Post-NPX
Pre-NPX wk 1 wk 2 wk 3
Zinc nEq
+Zn/S (N = 10) 99.3 9.4 116 16.3 129 ÷ 16.3 131 16.7
+ZnIN (N — 8) 94.8 17.5 129 13.2 169 33.6 158 23.1
—Zn/S (N = 12) 15.6 lI' 15.5 49a 13.9 1.4 16.3 ÷ 2.3
—Zn/N (N = II) 20.1 2.4 26.8 + 26.3 2.2" 34.3 5.2c
Calcium Eq
+Zn/S 3.0 + 0.37 3.8 0.33 4.8 0.97 5.3 1.1
+Zn/N 3.0 0.42 43,9 19.9 75 14.5 59
—Zn/S 2.8 0.42 4.6 0.60 4.8 0.75 7.5 1.3
—Zn/N 3.5 0.38 47.0 ÷ 8.4" 25.7 7.1" 41.6
Sodium p.Eq
+Zn/S 765 36.3 761 33.7 720 30.3 667 60
+Zn/N 785 35.2 757 48 649 71.1 739 38.2
—Zn/S 756 22.6 717 27.7 659 33.2 651 41.6
—Zn/N 817 32.9 780 60.1 748 71.2 772 -'- 92.7
Protein mg
+Zn/S 8.2 0.83 6.3 0.63' 7.2 1.2 6.0 0.87
+Zn/N 7.2 068a.d 12 076b.f II 3.7 18
—Zn/S 10 0.90 11 1.86" 9.7 0.81 7.2 0.63
Zn/N 14 2.2 16 1.9 16 + l.9t 21 3.7"
P < 0.005, +Zn vs. —Zn
h P < 0.005, N vs. sham
P < 0.005, compared to —Zn/S
d P < 0.01, compared to —Zn/S
P < 0.05, compared to +Zn/S
P < 0.05, +Zn vs. —Zn
Determinants of zinc excretion
Zinc replete Zinc deplete
' O.2E
C, 0
.0.200
.0 r=0.0890
o 0.15o
30>' 0
C) 00 03 00
C
' 0.05
0.1 G
0.08
0.06
r = 0.635
0.04 0
0.02
Co
'0510l52025303540 ''0 510152025303540
Urinary protein (mg/day/lOOg body weight)
Fig. 3. Urinary zinc and protein excretion in zinc replete and deplete
ani,nals. Zinc excretion correlated (P < 0.05) with protcin excretion
only in pooled zinc depleted animals.
protein excretion at sacrifice correlated with urinary zinc ex-
cretion in zinc deplete animals (r — 0.635, P < 0.01). However,
urinary protein excretion in +Zn/N animals had no statistically
significant correlation with urinary zinc excretion (Fig. 3).
Urinary zinc excretion was not correlated with creatinine
clearance in —Zn/N or —Zn/S animals, when analyzed sepa-
rately.
Urinary calcium excretion was similar in all groups before
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Table 4. Zinc and calcium fecal excretion and net balances (per 24 hours and 100 grams)
Post-NPX
Fecal zinc pLq
+Zn/S (N = 10)
+Zn/N (N = 8)
—Zn/S (N = 12)
—Zn/N(N= II)
Zinc balance p.Eq
+Zn/S
+Zn/N
—Zn/S
—Zn/N
Fecal calcium ,nEq
+Zn/S
+Zn/N
—Zn/S
—Zn/N
Calcium balance inEq
+Zn/S
+Zn/N
—Zn/S
-Zn/N
Pre-NPX
11.9 1.3
10.7 0.83
0.149 0012g
0.154 0.020
7.0± 1.2
8.0 0.98
—0.047 0.011
—0.056 0.019
0.74 0.06
0.69 0.08
0.63 0.05
0.59 0.07
0.53! 0.070
0.719 0.093
0.670 0.035
0.593 0.046
wk I
14.5 0.8
17.3
0.133 0006g
0.193 O.Ol5"
5.5 0.7
4.1 1.3"
—0.036 0.009
—0.113 0.021"-
0.77 0.06
0.82 0.1!
0.77 0.05
0.79 0.08
0.445 0.076
0.307 0.093"
0.453 0.082
0.397 0.083
wk 2
13.4 1.1
15.4 1.7"
0.167 002l
0.278 0051a,g
5.6 0.73
5.0 1.8
—0.070 0.028
—0.194 o.os2"'
0.81 0.03
0.85 0.10
0.81 0.06
0.70 0.06
0.239 0.060"
0.224 0.079
0.305 0.046
0.428 0.072
wk 3
11.9 0.63
12.! 1.6
0.173 00I8
0.200 0037g
6.8 0.7
7.6 1.2
—0.089 0.016"
—0.126 0.034
(1.60 0.06
0.90 0.11
0.79 0.09
0.66 0.11
0.334 0023a.g
0.214 0•080b
0.227 0.024
0.372 0067,1.f
nephrectomy. After nephrectomy, urinary calcium excretion
was not affected by zinc nutritional status. Urinary calcium was
consistently greater in all nephrectomized animals compared to
all sham controls, regardless of zinc nutritional status, (P <
0.005 for all observations, Table 3). Urinary zinc excretion at
sacrifice correlated well with urinary calcium excretion in zinc
deficient groups (r = 0.855, P < 0.005) but not in zinc replete
groups (Fig. 4).
Urinary sodium excretion was similar in all four groups
during all observation periods. Urinary zinc excretion did not
correlate significantly with urinary sodium excretion in any
individual group.
+Zn/N animals showed a significant (P < 0.05) increase in
fecal zinc excretion for two weeks after surgery compared to
their pre-nephrectomy fecal zinc excretion. Consequently in the
first week after nephrectomy there was a decrease in the
magnitude of the net positive zinc balance in the + Zn/N
animals compared to their pre-nephrectomy levels (P < 0,05).
There was no difference in zinc balance between + Zn/S and
+ Zn/N groups.
Pre-nephrectomy zinc balances were negative in all zinc
depleted animals. —Zn/N animals had a significantly larger
absolute fecal zinc excretion than —Zn/S controls during the
first post-operative week (P < 0.005). The negative zinc balance
in —Zn/N animals increased significantly in the first two weeks
after nephrectomy, compared to either their prenephrectomy
balance (P < 0.05) or —Zn/S controls' balance (P < 0.005 first
week, P < 0.05 second week, Fig. 5). Nephrectomy was
therefore associated with increased net zinc loss in zinc deplete
animals.
Calcium balances were positive in all groups at all times.
Nephrectomized groups' calcium balances were not different
from sham groups for any given week. However, the + Zn/N
group showed a significant reduction (P < 0.01) in calcium
balance when pre-nephrectomy levels were compared to sub-
sequent weeks' values. —Zn/N animals had a significant reduc-
tion (P < 0.02) only when the third week's calcium balance was
compared to pre-nephrectomized balance. Magnesium balance
was positive for all groups at all times and did not vary
significantly between groups.
Twenty-nine animals had determinations of hepatic cellular
P < 0.05 compared to pre-Npx values
P < 0.005 compared to pre-Npx values
P < 0.005 compared to —Zn/S
"P < 0.05 compared to —Zn/S
P < 0.01 compared to pre-Npx values
P < 0.02 compared to pre-Npx values
g P < 0.0001 compared to +Zn
Determinants ofzinc excretion
Zinc replete Zinc deplete
0)
a,
0
.0
0,00
'a0
C.
w
a
C
N
>-
'aC
0.02 0.04 0.06 0.08 00 0.02 0.04 0.06
Urinary calcium (MEq/day/100 g body weight)
Fig. 4. Urinary zinc and calcium excretion in zinc replete and deplete
animals. Zinc excretion correlated (P < 0.05) with calcium excretion
only in pooled zinc depleted animals.
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Fig. S. Zinc balance in zinc deplete nephreciomized and sham oper-
ated animals. —Zn/N animals had greater fecal zinc excretion the first
post-operative week compared to —Zn/S, but zinc balance was less in
this group for 2 weeks. Urinary zinc excretion was higher in —Zn/N
compared to —Zn/S for the entire observation period. Symbols are: (•)
P < 0.005 zinc balance (S vs. N); (A) P < 0.05 zinc balance (S vs. N);
(5) P < 0.005 fecal zinc (S vs. N); (t) P C 0.005 urinary zinc (S vs. N).
zinc concentration. The +Zn/S (N 9) group had a mean
hepatic zinc concentration of 2.30 0.36 rEq/g, significantly
higher (P C 0.002) than the mean hepatic zinc concentration of
the —Zn/S group (N = 9), 1.75 0.23 j.rEq/g (Fig. 6). The
+ Zn/N group (N = 4) had a mean hepatic zinc concentration of
2.40 0.39 LEq/g, not significantly different from the +Zn/S
group. The —Zn/N group (N = 7) had a significantly lower
hepatic zinc concentration, 1.48 0.17 rEq/g compared to zinc
replete animals with renal insufficiency (P C 0.0005) and zinc
deplete sham-operated controls (P C 0.02).
Discussion
The growth retardation observed in this pair-feeding study in
response to surgery and restriction of dietary zinc is consistent
with the well-known stunting effect of such a diet fed to
weanling rats [5]. Post-surgical anorexia induced weight loss
was not regained by —Zn animals, while pair-fed +Zn controls
recovered and exceeded their pre-surgical weight by the end of
the observation period. Both groups consumed equal quantities
of diet, identical in all respects except for zinc content, suggest-
ing that the zinc replete animals utilized their food more
efficiently, perhaps due to better absorption. Zinc nutritional
status rather than renal function seemed to be a more important
determinant of weight at sacrifice.
Substantial reduction in renal function was indicated by the
increased plasma creatinine concentrations and the decreased
creatinine clearances in the nephrectomized animals. Total
urinary creatinine and sodium excretion in all groups were
similar, Nephrectomized animals exhibited increased urine
volume and protein excretion, characteristic of uremia. Four
weeks after nephrectomy, urinary zinc excretion was signifi-
cantly elevated in —Zn/N animals, about twice that of control
—Zn/S animals. Hyperzincuria, however, was not a concomi-
tant of nephrectomy in zinc replete animals.
In the nephrotic syndrome, hyperzincuria has been attributed
to the increased urinary loss of protein [28]. Since plasma zinc
is extensively bound to protein [29, 301, an increase in urinary
protein excretion could theoretically account for the observed
hyperzincuria [31], In the present study, both urinary zinc and
Fig. 6. Hcpatic zinc concentration in the siady groups. Zinc concen-
tration was significantly greater in +Zn/S vs. —Zn/S, +Zn/N vs.
—Zn/N, and —Zn/S vs. —Zn/N groups. Symbols are: (•) P < 0.002
+Zn/Svs. —Zn/S;(flP<0.005 +Zn/Svs. —Zn/N;(t)PC0.02 —Zn/S
vs. —Zn/N.
protein excretion were elevated in —Zn/N animals. The corre-
lation coefficient (r = 0.635) for urinary zinc and protein
excretion suggests a relationship between these variables only
for the zinc deficient groups. For the same zinc deficient
groups, a better correlation (r = 0.855) existed between urinary
calcium and zinc excretion. This suggests that those factors
which influence urinary calcium excretion in uremia, such as
acidemia [32, 33], may also have resulted in an increase in
urinary zinc excretion.
In zinc replete animals, urinary zinc excretion was five to
eight times greater than that of zinc deplete animals. However,
nephrectomy in zinc replete animals caused no statistically
significant increase in urinary zinc excretion compared to
+Zn/S controls. Neither urinary calcium nor protein excretion
correlated with urinary zinc excretion in +Zn/N animals, The
higher rate of zinc excretion seen with zinc repletion may mask
the effect of uremia to increase urinary zinc excretion observed
in the zinc depleted animals.
Zinc deplete groups had lower urinary zinc excretion rates at
sacrifice which correlated with urinary protein excretion, flow,
and the ratio of urinary flow and creatinine clearance for the
pooled sample. This suggests that the rates of tubular flow and
urinary protein excretion are associated with the urinary zinc
excretion seen in the uremic zinc deplete group. Urinary
volume, sodium excretion and the ratio of urine flow and
glomerular filtration rate (V/GFR) have been shown to correlate
with urinary zinc excretion in a micropuncture study of volume
expanded chlorothiazide diuresis [34]. In the present, non-
volume expanded study, urinary sodium excretion did not
correlate with urinary zinc excretion in any group, nor did
urinary flow, or flow per creatinine clearance, in +Zn/N,
+Zn/S or —Zn/S groups. In zinc repletion, the greater urinary
zinc excretion unrelated to these factors may conceal the
underlying correlation with flow and protein excretion. Thus,
A• Fecal Zn tD Urinary Zn
+Zn/S —Zn/S +Zn/N —Zn/N
N=9 N=9 N=4 N=7
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the kidney's overall handling of zinc appears unimpaired by
renal insufficiency in rats fed a zinc replete diet.
In normal animals, urinary zinc excretion contributes little to
zinc homeostasis even over a wide range of zinc intake [351
presumably because of the low ultrafilterability of plasma zinc.
However, in animals with normal renal function, the relatively
low urinary zinc excretion rate may represent an important
factor in maintaining zinc balance when nutritional zinc intake
is inadequate [35].
The mechanism for the increased urinary zinc excretion in
animals with both renal insufficiency and zinc depletion is
unclear. Increased urinary protein excretion may account for
some hyperzincuria [28, 31]. In addition, changes in the binding
of zinc to plasma proteins may result in an increase in ultrafil-
terable zinc concentration [29, 301. The binding of zinc to
plasma proteins may be affected by the acid-base status of the
subject. Decreases in plasma pH are associated with increases
in ultrafilterable zinc concentration [36]. Since zinc deficiency
has been associated with diminution in carbonic anhydrase
activity [37], animals with combined zinc deficiency and uremia
may have had a greater tendency than other groups to develop
acidemia, secondary to limitation in urinary hydrogen ion
secretion. Alternatively, alterations in amino acid metabolism
may be associated with an increased urinary zinc excretion in
zinc depleted animals with renal insufficiency. Zinc deficiency
has been a:ssociated with increased plasma histidine concentra-
tion in rats [38]. Chronic renal insufficiency in man has been
associated with increases in plasma concentrations of lysine,
histidine and cysteine-homocysteine mixed disulfides [39—411.
Infusions of cysteine and histidine dramatically increase urinary
zinc excretion [42, 431. Since these amino acids may act as
ligands of zinc [29], increases in their plasma concentration
secondary to renal insufficiency and/or zinc depletion may
substantially increase the ultrafilterability of zinc. If an in-
creased filtered load of zinc is coupled with a reduced renal
reabsorptive capacity, a net increase in urinary zinc excretion
could result. This may represent an important route for zinc
loss only in the severely zinc depleted animal. Unfortunately
plasma and urinary concentrations of amino acids and acid-base
parameters were not measured in this study.
A temporary increase in fecal zinc excretion was observed
following nephrectomy in both zinc deficient and zinc replete
animals as compared to either sham operated animals or to their
pre-nephrectomy levels. Anorexia accompanied by a lower zinc
intake was not a factor in decreased zinc balance, since the
replete animals were given a fixed zinc supplement contained in
one gram of food consumed before the pair-determined allot-
ment of diet was given. Since there was virtual constancy of
zinc intake in the replete animals, and urinary zinc excretion is
relatively minor in terms of total zinc excretion, overall zinc
balance was largely determined by fecal zinc excretion. The
adverse effect of fecal zinc excretion on zinc balance for both
+Zn/N and —Zn/N animals suggest that renal insufficiency is
associated with a diminution in intestinal absorption or an
increase in intestinal secretion of zinc.
Similarly, the mechanism for the early increased fecal excre-
tion of zinc in animals with combined renal insufficiency and
zinc depletion is obscure. Data from humans with chronic renal
insufficiency suggests extensive compartmental shifts of zinc,
which may vary from organ to organ [181. Intestinal zinc
secretion has been demonstrated in vivo in animals and man
[44, 45]. Zinc secretion is most manifest in the absence of
intraluminal zinc [45]. A relatively high intestinal tissue con-
centration of zinc, in the face of increased non-protein bound
plasma zinc and relatively low intraluminal zinc concentrations
could account for a concentration gradient that might favor
intestinal zinc secretion in the —Zn/N animals.
Evaluation of hepatic zinc concentration yielded results
consistent with those of previous workers. There was no
difference between hepatic zinc concentration in zinc replete
groups with different levels of renal function. Zinc depleted
subjects had significantly lower hepatic tissue zinc concentra-
tions than zinc repleted controls, which is consistent with
reported studies [46, 47]. However, superimposition of renal
insufficiency resulted in a difference in hepatic zinc concentra-
tions between zinc depleted groups. The zinc deplete uremic
animals had significantly lower hepatic zinc concentrations than
their zinc depleted sham operated controls. The decreased
hepatic zinc concentration in the —Zn/N group suggests that
tissue sequestration of zinc is not an important modulator of the
hypozincemia associated with zinc depletion in uremia. The
lower hepatic zinc concentration in the —Zn/N group may in
part account for the similarity in the plasma zinc concentrations
in both zinc deplete groups, with strikingly different zinc
balances if this effect on tissues is generalized. A more com-
plete analysis of tissue depots of zinc than was performed in the
present study will be necessary to fully assess the contribution
of redistribution of zinc stores in uremic subjects with hypo-
zincemia.
Condon and Freeman [6] could not document differences in
hepatic zinc concentration post mortem in uremic dialyzed and
non-dialyzed patients, compared to controls without renal
insufficiency, or in acutely uremic rats compared to animals
with normal renal function on the same diets. Smythe et al [18]
found significantly higher hepatic tissue zinc concentrations in
subjects with uremia compared to normal controls. That data
may reflect higher zinc intake or better nutritional status in the
studied patients with uremia compared to the severe model of
zinc depletion employed in our study. In the present study,
hepatic zinc concentration in zinc replete subjects with uremia
was greater than that of the +Zn/S group, but the difference
between groups was not significant. However, investigators
have suggested that repletion with dihydroxycholecalciferol
and high parathyroid hormone levels may increase hepatic zinc
concentrations in uremia [48]. These factors were not evaluated
in the present study, but might account for some of the
observations and inconsistencies in the literature.
The hypozincemia observed in animals with renal insuffi-
ciency is associated with net negative zinc balance. Zinc
balance in uremic animals is primarily determined by the
availability of nutritional zinc, rather than degree of renal
function impairment. Changes in hepatic compartmentalization
of zinc occur but do not seem to contribute to the development
of hypozincemia, and may contribute to maintenance of extra-
cellular fluid zinc concentration in uremic zinc depleted ani-
mals. Other tissues may, however, have an effect on the
distribution of total body zinc in this model. In the case of zinc
depletion in renal insufficiency, both renal and gastrointestinal
conservatory mechanisms are inadequate to prevent the devel-
opment of negative zinc balance. Quantitatively, gastrointesti-
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nal losses represent the major factor in the development of
negative zinc balance in zinc deplete animals after the onset of
renal insufficiency.
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